India’s Zydus Life reports higher quarterly profit on new drug launches in US
(Reuters) -Indian drugmaker Zydus Lifesciences reported a higher adjusted fourth-quarter profit on Tuesday, driven by new drug launches in the U.S., its biggest market. The company reported a 22% rise in its consolidated profit before exceptional items and tax to 18.92 billion rupees ($221.3 million) for the quarter ended March 31. However, Zydus Life recorded …
India’s Zydus Life reports higher quarterly profit on new drug launches in US Read More »








